Oral prolonged-release dienogest 2 mg and ethinylestradiol 0.02 mg in a 24/4-day regimen for polycystic ovary syndrome-associated hirsutism: a double-blind, randomised, placebo-controlled trial.

ABSTRACT:

SUBMITTER: Lobo R 

PROVIDER: S-EPMC12615318 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature